argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx’s first experimental medicine, efgartigimod, is being evaluated in multiple autoimmune diseases, including myasthenia gravis (MG), pemphigus vulgaris (PV), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). argenx is located in Ghent, Belgium, Boston, Massachusetts and Tokyo, Japan.

The BIS (Business Information Systems) AI & Emerging Technologies Platform lead will oversee the strategic development and operational execution of AI solutions to assure accelerated broad adoption across all domains of the pharmaceutical development lifecycle. This role will work closely with cross-functional teams to ensure easy access to solutions appropriate to drive adoptions.

The individual in this role is a key leader within the BIS R&D team reporting to the Data Management & AI Lead.

ROLES AND RESPONSIBILITIES:

EDUCATION, EXPERIENCE AND QUALIFICATIONS:

Join us at argenx and be part of a collaborative and passionate team dedicated to advancing breakthrough therapies for patients in need. Together, we can make a difference in the lives of millions worldwide.